Where does Multi Radiance Medical rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Multi Radiance Medical ranks #26,911 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Multi Radiance Medical hold?

Multi Radiance Medical holds 10 US utility patents granted between 2020 and 2023, spanning 3 technology areas.

What is Multi Radiance Medical's Innovation Score?

Multi Radiance Medical has an Innovation Score of 27.1 out of 100 (23rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Multi Radiance Medical focus on?

Multi Radiance Medical's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 9 patents, ranking #407 of 1,943 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Multi Radiance Medical's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Multi Radiance Medical.

What does claim depth mean for Multi Radiance Medical's patents?

Multi Radiance Medical's patents average 13.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Multi Radiance Medical patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Multi Radiance Medical

USPTO PatentsView assignee record - 10 granted patents across 3 technology areas, recorded in grant years 2020–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Multi ranks #26,911 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 3 technology areas.

#26,911
of 49,997 US assignees by volume: 23rd percentile
by Innovation Score (27.1/100): 13.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R26911 · US Corporation #26,911 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 10 grants
MID-PACK #26,911/49,997
PHOTO-FINISH MSM Innovations
CPC-NARROW A61N · 3 areas
INNOV-THIN 27.1/100
CLAIMS-RICH 13.8 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2023 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: MSM Innovations, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Multi’s 27.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (31%) Velocity 4.4 pts (16%) Breadth 6.1 pts (23%) Claim depth 8.3 pts (31%)

Qualcomm Incorporated · highest

85
Multi Radiance Medical · this assignee

27
3D Lighting… · lowest

7

What this shows Multi's Innovation Score is 27.1/100 (23rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Multi?

Each dot is one of Multi’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Multi’s own 13.8 claims/patent is at or below the 15.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Multi vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Multi's grants concentrate

Multi Radiance Medical is a focused PatentsView assignee: 3 CPC subclasses with 90% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2020 (3 grants) versus a trough of 2 in 2022. By volume, Multi sits between MSM Innovations, Inc. and MY Virtual Reality Software AS.

Multi's three-year grant acceleration

Multi Radiance Medical shows 4 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

MSM Innovations

10
MSP

10
MTE

10
MTI Baths

10
Murata OY

10
Mutabilis

10
Muviq S R L

10
MY Virtual Realit…

10
Multi Radiance Me… ◀

10

What this shows Multi holds 10 patents at rank #26,846, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Multi

By rank, the assignees closest to #26,846 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Multi's primary technology class.

Multi's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 23rd percentile higher than 23% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Multi Radiance Medical patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	3	30.0%
2021	3	30.0%
2022	2	20.0%
2023	2	20.0%

Which technologies does Multi Radiance Medical patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 9

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Multi Radiance Medical's patent record in context - here's where to go next.

Multi Radiance Medical's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 90% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #26,911 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Multi Radiance Medical against MSM Innovations, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.